دورية أكاديمية

Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial

التفاصيل البيبلوغرافية
العنوان: Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial
المؤلفون: Naglaa Agamia, Marwa Essawy, Amira Kassem
المصدر: Journal of Dermatological Treatment, Vol 33, Iss 2, Pp 904-909 (2022)
بيانات النشر: Taylor & Francis Group, 2022.
سنة النشر: 2022
المجموعة: LCC:Dermatology
مصطلحات موضوعية: post- acne erythema, topical oxymetazoline, liposomal base, microneedling, Dermatology, RL1-803
الوصف: Background Post-inflammatory erythema (PIE) is a common sequalae of acne inflammation, persistent post acne erythema (PAE) is cosmetically unacceptable and sometimes its complete clearance could not be achieved. Oxymetazoline (OXZ) is a synthetic, direct-acting, sympathomimetic agonist that is highly selective for the 1α-adrenoceptor. It is a potent vasoconstrictor and well known for its ability to clinically ‘get the red out’. Aim The aim of this study was to evaluate the efficacy and safety of topical oxymetazoline (OXZ) 1.5% in treatment of post acne erythema (PAE) in a left to right face comparative study. Methods This study was conducted on 40 patients diagnosed with post acne erythema for at least 3 months, the left side of the face was treated with topical OXZ 1.5% in liposomal base and was compared to the right side to which topical lipogel was applied as a control. Results According to the investigator’s global assessment of photographs and the analysis of erythema with image analysis software, topical OXZ was significantly effective in diminishing PAE when compared to topical placebo lipogel Conclusion Topical OXZ is a safe and effective treatment for post-acne erythema.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0954-6634
1471-1753
09546634
Relation: https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753
DOI: 10.1080/09546634.2020.1789045
URL الوصول: https://doaj.org/article/94fd8bae2e3343039ca541d35b4697d3
رقم الأكسشن: edsdoj.94fd8bae2e3343039ca541d35b4697d3
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:09546634
14711753
DOI:10.1080/09546634.2020.1789045